All four were CD10+ and CD38+, suggesting that CD19+CD10+CD38+ cell populations might be a useful as a panel to determine the establishment of PDOX in this type of B-ALL. This evidence concerns the gene CD38 and precursor B-cell acute lymphoblastic leukemia.